source
- CVS obesity drug deal puts Lilly on equal footing with NovoThe agreement includes Lilly’s new pill Foundayo and restores coverage for Zepbound, erasing what had been a commercial edge for rival Novo Nordisk.BioPharma Dive · 2mo ago↗ source
- FDA Approves First Treatment for Chronic Hepatitis Delta Virus (HDV) InfectionToday, the U.S. Food and Drug Administration approved Hepcludex (bulevirtide-gmod) injection to treat chronic hepatitis delta virus (HDV) infection in adults without cirrhosis (advanced liver scarr…fda press · 2mo ago↗ source
- FDA Warns Retailers Selling Illegal Tobacco Products That Look Like Everyday ProductsFDA Warns Retailers Selling Illegal Tobacco Products That Look Like Everyday Productsfda press